Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Baxter
Medtronic
Dow
Julphar
US Department of Justice
Harvard Business School
AstraZeneca
Fuji

Generated: June 18, 2018

DrugPatentWatch Database Preview

Prinston Inc Company Profile

« Back to Dashboard

What is the competitive landscape for PRINSTON INC, and what generic and branded alternatives to PRINSTON INC drugs are available?

PRINSTON INC has fifty-three approved drugs.

There is one tentative approval on PRINSTON INC drugs.

Summary for Prinston Inc
US Patents:0
Tradenames:45
Ingredients:45
NDAs:53

Drugs and US Patents for Prinston Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc GLIMEPIRIDE glimepiride TABLET;ORAL 077370-001 Dec 23, 2005 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Prinston Inc CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE candesartan cilexetil; hydrochlorothiazide TABLET;ORAL 207455-002 Apr 11, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Prinston Inc FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 205670-002 Aug 29, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Prinston Inc LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 204901-003 Nov 6, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Medtronic
Merck
Covington
Teva
Federal Trade Commission
Julphar
US Department of Justice
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.